421 – 430 of 553
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study
(
- Contribution to journal › Article
-
Mark
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Prediction of falls and/or near falls by using tandem gait performance in people with mild Parkinson’s disease
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis.
(
- Contribution to journal › Article
-
Mark
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease : A prospective 9-year study
(
- Contribution to journal › Article
- 2014
-
Mark
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
(
- Contribution to journal › Article
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Factors associated with fear of falling in people with Parkinson's disease.
(
- Contribution to journal › Article